These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17420112)

  • 1. A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model.
    Goldoni M; Johansson C
    Toxicol In Vitro; 2007 Aug; 21(5):759-69. PubMed ID: 17420112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel dose-response curves in combination experiments.
    Sühnel J
    Bull Math Biol; 1998 Mar; 60(2):197-213. PubMed ID: 9559575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response or dose-effect curves in in vitro experiments and their use to study combined effects of neurotoxicants.
    Goldoni M; Tagliaferri S
    Methods Mol Biol; 2011; 758():415-34. PubMed ID: 21815082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical formulation of additivity for antimicrobial agents.
    Boucher AN; Tam VH
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):319-25. PubMed ID: 16626903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fitting models for the joint action of two drugs using SAS.
    Whitehead A; Whitehead J; Todd S; Zhou Y; Smith MK
    Pharm Stat; 2008; 7(4):272-84. PubMed ID: 17979217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic effects of methyl-mercury and PCB153 on PC12 cells after a combined and simultaneous exposure.
    Vettori MV; Goldoni M; Caglieri A; Poli D; Folesani G; Ceccatelli S; Mutti A
    Food Chem Toxicol; 2006 Sep; 44(9):1505-12. PubMed ID: 16757078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unifying concept for assessing toxicological interactions: changes in slope.
    Gennings C; Carter WH; Carchman RA; Teuschler LK; Simmons JE; Carney EW
    Toxicol Sci; 2005 Dec; 88(2):287-97. PubMed ID: 16081521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction index and different methods for determining drug interaction in combination therapy.
    Lee JJ; Kong M; Ayers GD; Lotan R
    J Biopharm Stat; 2007; 17(3):461-80. PubMed ID: 17479394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theory of synergistic effects: Hill-type response surfaces as 'null-interaction' models for mixtures.
    Schindler M
    Theor Biol Med Model; 2017 Aug; 14(1):15. PubMed ID: 28768512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose addition and the isobole method as approaches for predicting the cumulative effect of non-interacting chemicals: a critical evaluation.
    Bosgra S; van Eijkeren JC; Slob W
    Crit Rev Toxicol; 2009; 39(5):418-26. PubMed ID: 19514914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying synergism/antagonism using nonlinear mixed-effects modeling: a simulation study.
    Boik JC; Newman RA; Boik RJ
    Stat Med; 2008 Mar; 27(7):1040-61. PubMed ID: 17768754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple test for synergy for a small number of combinations.
    Novick SJ
    Stat Med; 2013 Dec; 32(29):5145-55. PubMed ID: 23904140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions in developmental toxicology: a literature review and terminology proposal.
    Nelson BK
    Teratology; 1994 Jan; 49(1):33-71. PubMed ID: 8171395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CombiTool--a new computer program for analyzing combination experiments with biologically active agents.
    Dressler V; Müller G; Sühnel J
    Comput Biomed Res; 1999 Apr; 32(2):145-60. PubMed ID: 10337496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing experimental designs for benchmark dose calculations for continuous endpoints.
    Kuljus K; von Rosen D; Sand S; Victorin K
    Risk Anal; 2006 Aug; 26(4):1031-43. PubMed ID: 16948695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial combinations: Bliss independence and Loewe additivity derived from mechanistic multi-hit models.
    Baeder DY; Yu G; Hozé N; Rolff J; Regoes RR
    Philos Trans R Soc Lond B Biol Sci; 2016 May; 371(1695):. PubMed ID: 27160596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design Recommendations.
    Chen C; Wicha SG; Nordgren R; Simonsson USH
    AAPS J; 2018 Jun; 20(4):77. PubMed ID: 29931471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonlinear statistical models for the joint action of toxins.
    Barton CN; Braunberg RC; Friedman L
    Biometrics; 1993 Mar; 49(1):95-105. PubMed ID: 8513113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is synergy? The Saariselkä agreement revisited.
    Tang J; Wennerberg K; Aittokallio T
    Front Pharmacol; 2015; 6():181. PubMed ID: 26388771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.